✦ LIBER ✦

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy: Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Scribed by Harvey D. White; Derek P. Chew; James W. Hoekstra; Chadwick D. Miller; Charles V. Pollack Jr; Frederick Feit; A. Michael Lincoff; Michel Bertrand; Stuart Pocock; James Ware; E. Magnus Ohman; Roxana Mehran; Gregg W. Stone

Book ID: 119267322
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 228 KB
Volume: 51
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2007.12.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Bivalirudin Monot

Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes: A Report From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial

✍ Frederick Feit; Steven V. Manoukian; Ramin Ebrahimi; Charles V. Pollack; E. Magn 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 394 KB

Safety and Efficacy of Bivalirudin With

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Intraprocedural Thrombotic Events During

Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Are Associated With Adverse Outcomes: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial

✍ Margaret B. McEntegart; Ajay J. Kirtane; Ecaterina Cristea; Sorin Brener; Roxana 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Enoxaparin vs. unfractionated heparin in

Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-Segment elevation acute coronary syndromes managed with an intended early invasive strategy—primary results of the SYNERGY randomized trial

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Impact of Delay to Angioplasty in Patien

Impact of Delay to Angioplasty in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Paul Sorajja; Bernard J. Gersh; David A. Cox; Michael G. McLaughlin; Peter Zimet 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 761 KB

Efficacy and safety of enoxaparin compar

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial

✍ Harvey D. White; Neal S. Kleiman; Kenneth W. Mahaffey; Yuliya Lokhnygina; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 333 KB